Antileishmanial Activity of Ampbotericin B Entrapped in Cationic Liposomal Formulation | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Antileishmanial Activity of Ampbotericin B Entrapped in Cationic Liposomal Formulation

Implementing Organization

Indian Institute of Chemical Engineers

Indian Institute of Chemical Biology (IICB)

About

A novel method of treatment of Kala Azar using medicament comprising of antileishmanial amphotericin B encapsulated in leishmaniacidal cationic liposome.

Patent Details

IN264798

Related Research

Quick Information

Area of Research

Pharmaceutical Sciences

Focus Area

Treatment of Kala azar

Status

completed

Patent No.

IN264798

Output in Numbers

Research Paper

00

Technologies (If Any)

00

PhD Produced

N/A

Startup (If Any)

00

Patents

Filed :01

Grant :00